Abstract-Hyperglycemia-induced oxidative stress may play a key role in the pathogenesis of diabetic vascular disease. The purpose of this study was to determine the effects of glucose on levels of glutathione (a major intracellular antioxidant), the expression of ␥-glutamylcysteine synthetase (the rate-limiting enzyme in glutathione de novo synthesis), and DNA damage in human vascular smooth muscle cells in vitro. High glucose conditions and buthionine sulphoximine, an inhibitor of ␥-glutamylcysteine synthetase, reduced intracellular glutathione levels in vascular smooth muscle cells. This reduction was accompanied by a decrease in the mRNA expression of both subunits of ␥-glutamylcysteine synthetase as well as an increase in DNA damage. In high glucose conditions, incubation of the vascular smooth muscle cells with ␣-lipoic acid and L-cystine restored glutathione levels. We suggest that the decrease in GSH levels seen in high glucose conditions is mediated by the availability of cysteine (rate-limiting substrate in de novo glutathione synthesis) and the gene expression of the ␥-glutamylcysteine synthetase enzyme. Glutathione depletion is associated with an increase in DNA damage, which can be reduced when glutathione levels are restored.
INTRODUCTION
Vascular disease is responsible for most of the long-term complications of diabetes mellitus, and these changes are associated with hyperglycemia-induced oxidative stress. Glutathione (GSH), an important intracellular antioxidant, is depleted in erythrocytes [1] , plasma [2] , leucocytes [3] , and platelets from human diabetic patients [4] and in endothelial cells from diabetic rabbits [5] . The changes in GSH levels, which result in an oxidant/prooxidant imbalance, may predispose the cells to oxidantinduced damage and diabetic complications.
GSH is the principal intracellular thiol and provides defense against oxidative stress by scavenging free radicals or causing the reduction of hydrogen peroxide. Under conditions of oxidative stress, GSH is oxidized to glutathione disulphide (GSSG) by glutathione peroxidase (GPx); GSSG is then reduced to GSH by glutathione reductase through the coupling reaction of NADPH to NADP. Hence, GSH influences the redox status of the cell, which is critical for various biochemical functions including modulation of the activity of redox-sensitive transcription factors [6, 7] , transcription of specific genes, regulation of cell proliferation, and apoptosis [8] .
GSH is synthesized from its constituent amino acids (glutamate, cysteine, and glycine) by the activity of two ATP-dependent enzymes, ␥-glutamylcysteine synthetase (␥-GCS) and glutathione synthetase with ␥-GCS, catalyzing the rate-limiting step of GSH synthesis [9] . Gamma-GCS is a heterodimer composed of a heavy (73 kDa) and light (29 kDa) subunit. The heavy subunit (␥-GCS H ) exhibits catalytic activity and is subject to nonallosteric inhibition by GSH [10] . The light subunit (␥-GCS L ) regulates the catalytic activity of the heavy subunit [11] . Two distinct genes encode the heavy and light subunits and marked tissue-specific expression of the subunits have been observed, which may contribute to tissuedependent regulation of enzymatic activity [12] .
Several studies have demonstrated the reductions in gene expression of the heavy subunit of ␥-GCS and activity of ␥-GCS in high-glucose conditions [13] [14] [15] . However, regulation of ␥-GCS activity at the mRNA level with respect to both the light and heavy subunits has not been investigated in high glucose conditions. In view of the importance of GSH in hyperglycemia-induced oxidative stress, the effects of high glucose on GSH synthesis, ␥-GCS mRNA expression, and DNA damage were investigated in human vascular smooth muscle cells (HVSMC).
EXPERIMENTAL PROCEDURES

Tissue culture materials and reagents
All chemicals were obtained from Sigma Chemical Co. (St. Louis, MO, USA) unless otherwise stated. RPMI 1640, L-cystine, and fetal calf serum (FCS) were purchased from Life Technologies (Gaithersburg, MD, USA).
Isolation and culture of HVSMC
HVSMC were obtained from aortae of transplant donors after written consent was obtained from the relevant family member (the study was approved by the Ethical Committee of Queen's University of Belfast). Cells were isolated from the infra-renal portion of the thoracic aorta as follows: the medial layer was separated from the intima and adventitial layers and cut into pieces approximately 1 mm 2 . The tissue was transferred into 25 cm 2 tissue culture flasks pre-moistened with FCS and containing RPMI supplemented with antibiotics (100 g/ml streptomycin sulphate and 60 g/ml benzylpenicillin), L-glutamine (2 mM), and 10% FCS. The flasks were placed in an incubator at 37°C in a 5% CO 2 atmosphere and left undisturbed for 7 d. After this the growth medium was changed twice weekly. Within 7-14 d, HVSMC grew out from the explants reaching confluence within 2 to 3 weeks and were harvested by conventional trypsinization and split for further culture into 75 cm 2 tissue culture flasks.
HVSMC were cultured for 10 d in normal glucose (5 mM, NG), high glucose (25 mM, HG), and NG ϩ L-buthionine-S,R-sulphoximine (10 M, BSO). The medium was replaced twice weekly and all experiments were performed on cells up to and including the eighth passage. Alpha-lipoic acid (25-100 M) or L-cystine (1.5-2.5 mM) were added to the cells up to 48 h prior to extraction.
Harvesting of HVSMC for GSH and protein analysis
Confluent HVSMC monolayers were rinsed with PBS and scraped in ice-cold Hanks balanced salt solution (HBSS, Life Technologies). The cells were centrifuged at 225 ϫ g at 4°C for 10 min, the supernatant aspirated, and the resulting cell pellets stored at Ϫ80°C.
Determination of intracellular glutathione (GSH)
The cell pellets were thawed on ice and resuspended in 0.1% Triton X-100 in PBS (pH 7.4). Sonication was performed as previously described [16] . The samples were stabilized by the addition of 10% sulphosalicylic acid (SSA). After centrifugation at 13,000 ϫ g for 5 min, the supernatant was analyzed for GSH according to the method described by Griffith [17] , which has been automated on the Cobas Fara centrifugal analyzer.
Protein determination
Total protein was measured using a bicinchoninic acid (BCA) protein assay reagent kit (Pertio Science Ltd, Cheshire, UK). Bovine serum albumin (BSA) was used as a standard.
Measurement of DNA damage
The single-cell gel electrophoresis or comet assay is a microgel electrophoretic technique for the detection of DNA damage and repair in individual cells [18] . Frosted microscope slides were coated with 0.75% normal melting point agarose and allowed to set at 4°C. Cells were trypsinized as described previously, centrifuged, and resuspended in 4 ml of DMEM. An aliquot (15 l) of the cell suspension was mixed with 112 l of 0.75% low melting point agarose and pipetted onto the frosted microscope slides, covered with a coverslip, and allowed to set at 4°C away from direct light. The slides were placed in lysis buffer (2.5 mM NaCl, 100 mM EDTA, 10 mM Trizma Base pH 10, 0.1% Triton X-100) for 1 h at 4°C, to allow disruption of the DNA base pairs, leaving only nuclear constituents intact. The slides were then placed in electrophoresis solution (300 mM NaOH, 1 mM EDTA) and the DNA allowed to unwind for 20 min. The current was applied for exactly 20 min at 20 V and 300 mA. During electrophoresis the cellular DNA migrates towards the anode, hence forming a comet "tail." After electrophoresis the slides were gently removed and the alkaline pH neutralized with 0.4 M Tris (pH 7) for 20 min. Excess solution was removed before addition of ethidium bromide (50 l of a 20 g/ml solution [EtBr]) to each slide. A coverslip was placed onto each slide prior to storage at 4°C.
Image analysis
The slides were viewed using a fluorescence microscope and DNA damage quantified using the Komet 3.1 analysis package (Kinetic Imaging, UK). At least 50 cells for each condition were analyzed. The "comet" appears as a "head," which contains undamaged DNA, and a "tail," which contains damaged DNA. The level of DNA damage is directly proportional to length of the comet tail and intensity of the Et Br staining [19] .
Design of ␥-GCS heavy and light subunit primers
Primers were designed using published human glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 20), ␥-GCS heavy subunit (21), and ␥-GCS light subunit (12) cDNA sequences. Gamma-glutamylcysteine synthetase light subunit (␥-GCS L ) primers (5Ј-TGC CTC AAT GAC ACC ATT TAC-3Ј, 5Ј-AAC CAA GTT AAT CTT GCC TCC-3Ј), ␥-glutamylcysteine synthetase heavy subunit (␥-GCS H ) primers (5Ј-AAC TCC CTC ATC CAT CTG G-3Ј, 5Ј-AGA GAT GCT GTC TTG CAG G-3Ј), and GAPDH primers (5Ј-AGG GAC TCA TGA CCA CGG-3Ј, 5Ј-TTG GAG GCC ATG TGG ACC-3Ј) were synthesized.
Extraction of total RNA and semiquantitative PCR
Total RNA was extracted according to the method of Chomczynski and Sacchi [22] . RNA (1 g) was reverse transcribed using an oligo (dT) primer and Superscript RNase H Ϫ reverse transcriptase system (Life Technologies). An aliquot (2 l) of the subsequent cDNA was added directly to the PCR mastermix containing: 100 pmoles of sense and antisense primers, 200 M dNTP, 1.5 U Taq DNA polymerase, 10ϫ PCR buffer (200 mM Tris-HCl (pH 8.4), 500 mM KCl, 2.5 mM MgCl 2 ), and 10 Ci 32 P-dCTP (NEN Life Sciences, Hounslow, UK, 370 MBq/ml). During PCR, aliquots were withdrawn at regular intervals (15, 20, 25, 30, 35, 40 , or 45 cycles) of amplification. An aliquot was electrophoresed in 1% agarose and radioactivity was determined on a Bio-Rad Molecular Imager system (Bio-Rad, Richmond, CA, USA). The exponential phase of the reaction was determined by plotting the amount of radioactivity from PCR products against the number of PCR cycles. Target mRNA was then coamplified with the internal control (GAPDH) using a Hybaid thermal cycler with the following cycling times and temperatures: 25 cycles of 94°f or 45 s, 55°for 1 min, and 72°for 1 min. The PCR reaction products were electrophoresed in a 1% agarose gel and fixed with 7% trichloroacetic acid. PCR products were quantified and normalized to GAPDH using a BioRad Molecular Imager System GS-525 (Bio-Rad, Hertfordshire, UK) and Molecular Analyst Software.
Statistical methods
Statistical analysis was performed using Student's t-tests.
RESULTS
Effects of glucose on intracellular GSH levels
To investigate the effect of glucose on GSH levels in vascular smooth muscle cells, HVSMC were incubated with 5 mM (NG) and 25 mM (HG) glucose for 10 d prior to cellular GSH determination. GSH levels were significantly decreased in cells treated with high glucose; similarly, treatment of cells grown in NG with BSO (an inhibitor of ␥-GCS) reduces GSH in HVSMC (Fig. 1) .
Effects of ␣-lipoic acid and L-cystine on intracellular GSH levels
To further investigate the mechanism by which GSH is depleted, ␣-lipoic acid or L-cystine were added to HVSMC in order to restore GSH levels to normal. Preliminary experiments using a range of concentrations of both ␣-lipoic acid (25-100 M) and L-cystine (1.5-2.5 mM) were performed (data not shown), and the concentrations at which GSH levels were restored to normal were used in subsequent experiments. Addition of ␣-lipoic acid (50 M), resulted in a significant elevation of GSH levels in HG-but not in NG/BSO-treated HVSMC after 24 h (Fig 1) . Alpha-lipoic acid (50 -500 M) has been shown to substantially increase GSH levels in vitro [23] and in vivo [24] by improving cysteine utilization. For ␣-lipoic acid to be effective, cells must possess functioning ␥-GCS to cause an increase in GSH [23] . The addition of ␣-lipoic acid did not significantly increase GSH levels in NG/BSO-treated cells indicating that inactivation of ␥-GCS had occurred.
Likewise, addition of L-cystine (2 mM) to cells grown in high glucose conditions but not in NG/BSO-treated cells resulted in a complete restoration of GSH levels after 24 h (Fig 1) . L-cystine increases GSH in HVSMC treated with HG but does not significantly elevate GSH in BSO-treated cells; therefore, the mechanisms by which HG and BSO decrease GSH in HVSMC are different.
Effects of glucose, BSO, ␣-lipoic acid, and L-cystine on DNA damage
GSH is an important antioxidant and the reduction in levels that occurs when HVSMC are exposed to high glucose conditions may be the primary event that predisposes the cells to oxidant-induced damage. To investigate the relationship between GSH levels and DNA damage, the comet assay was used, results of which are shown in Fig. 2 . The amount of DNA damage as measured by the percentage comet tail, was significantly increased in HVSMC cultured in high glucose for 10 d.
Likewise, the addition of BSO resulted in a significant increase in DNA damage of similar magnitude to that observed in HG conditions. When GSH levels were increased by the addition of ␣-lipoic acid or L-cystine, the DNA damage was reduced (Fig. 2) .
Effects of glucose, BSO, ␣-lipoic acid, and L-cystine on the mRNA expression of ␥-GCS heavy subunit
Gamma-GCS H subunit mRNA expression was determined by semiquantitative PCR using gene-specific primers to human ␥-GCS H cDNA sequence. GAPDH, a constitutively expressed enzyme, served as an internal control. Values were corrected for GAPDH and expressed as a percentage of NG (Table 1) . Incubation of HVSMC with HG and NG/BSO for 10 d caused a significant reduction in ␥-GCS H subunit mRNA expression compared to NG. Gamma-GCS H mRNA expression was unaffected by treatment of HVSMC with ␣-lipoic acid or L-cystine (Table 1) .
Effects of glucose, BSO, ␣-lipoic acid, and L-cystine on the mRNA expression of ␥-GCS light subunit
As observed with the heavy subunit, incubation of HVSMC with HG and NG/BSO for 10 d caused a significant reduction in ␥-GCS L subunit mRNA expression compared to NG (Table 1) . However, in contrast to the heavy subunit, ␣-lipoic acid and L-cystine significantly increased the mRNA expression of ␥-GCS L in comparison to high glucose alone, with ␣-lipoic acid causing the greatest increase (Table 1) .
DISCUSSION
Oxidative stress occurred in HVSMC cultured in HG; this was evidenced by both a fall in GSH levels and an increase in DNA fragmentation. HVSMCs cultured in high glucose conditions for 10 d show a reduction of approximately 30% in intracellular GSH. A decrease in ␥-GCS mRNA expression and increase in DNA damage accompany this reduction. The decrease observed is in agreement with published results; Yoshida et al. [15] found GSH levels 77% of controls in erythrocytes from diabetic patients, Urata et al. [14] reported GSH levels 59% of normal glucose after 7 d in 22 mM glucose, and Tachi et al. [25] found a decrease of 20% in HVSMC exposed to 27.5 mM glucose for 10 d. The depletion of GSH may be brought about through a variety of mechanisms, including an increased breakdown of GSH by ␥-glutamyltranspeptidase, an increased export of GSSG from the cell, or a reduction in de novo synthesis through reduced activity of ␥-GCS or availability of substrate. In human vascular smooth muscle cells, there is no significant difference in the rate of GSH efflux between cells exposed to high glucose compared to those in normal glucose [25] . The results from our study would suggest that in HVSMC the decrease is mediated by the availability of cyst(e)ine and gene expression of ␥-GCS during HG conditions.
Treatment of the cells grown in HG with ␣-lipoic acid (50 M) or L-cystine (2 mM) for 24 h significantly increased GSH to near normal levels. By contrast, neither ␣-lipoic acid nor L-cystine had any effect on GSH levels in HVSMC exposed to NG/BSO. Alpha-lipoic acid and L-cystine both increase the availability of cysteine intracellularly and require functional ␥-GCS to restore GSH levels. Alpha-lipoic acid not only functions as an antioxidant but it is reduced to dihydrolipoate intracellularly; dihydrolipoate is released from the cell into the culture medium where it reduces extracellular cystine to cysteine. Cysteine is taken up by the cell via the Na ϩ -dependent neutral amino acid transport system, ASC, thereby bypassing the cystine transport system x c Ϫ , and results in GSH synthesis. The supply of cyst(e)ine is rate limiting for synthesis of GSH in many cell types. In plasma and tissue culture media, cystine is the predominant form as cysteine is rapidly oxidized to cystine and may only be present in tissue culture medium for up to 30 min, so there is a relatively short period for uptake to occur. Cystine transport is mediated by a Na ϩ -independent anionic amino acid transport system x c Ϫ , which exchanges cystine for intracellular glutamate [26] and is inhibited by glutamate. Intracellularly cystine is reduced to cysteine, which is utilized for GSH de novo synthesis. Inhibition of cystine influx has been shown to decrease intracellular GSH and conversely induction of cystine transport increases GSH content [27] ; therefore, system x c Ϫ is important in maintaining GSH levels in various cell types [28 -31] . In human umbilical vein endothelial cells [32] and rat pancreatic acinar and islet cell lines [27] , inhibition of GSH synthesis by BSO treatment, without altering cystine transport, results in accumulation of cysteine within the cell. The fact that ␣-lipoic acid and L-cystine significantly elevate GSH levels would lead to the assumption that in HG conditions unlike in NG/BSOtreated cells, there is no inactivation of ␥-GCS in HVSMC and the availability of cyst(e)ine is rate-limiting. However it is possible that the restoration of GSH levels may be due to the additional effects of ␣-lipoic acid and L-cystine on gene expression of the ␥-GCS subunits.
Although much is known about the stimuli that increase or decrease ␥-GCS, the detailed mechanism of regulation is not completely understood [33] . Several studies have demonstrated the presence of AP-1, AP-2, antioxidant response elements (ARE)/electrophile response elements (EpRE), and SP-1 binding sites in 5Ј region upstream of the transcription start site of the two subunits of ␥-GCS [34, 35] . The increased transcription of ␥-GCS induced by agents such as xenobiotics is under the control of ARE/EpRE, which bind AP-1-like and NF-E2-like transcription factors [36] . AP-1 is known to be activated by high glucose conditions [37] , but there are no studies to date examining the activity of NF-E2 transcription factors in cells exposed to high glucose. Gamma-GCS is a heterodimer composed of a catalytic heavy subunit that comprises all substrate binding sites and a light subunit that modulates the affinity of the heavy subunit for its substrates. Induction of ␥-GCS expression by oxidative stress is well established [38 -40] , however exposure to high-glucose conditions decreases mRNA expression of both subunits in HVSMC. Urata et al. [14] found that high concentrations of glucose in endothelial cells decreased GCS H mRNA expression and inhibited the stimulatory effect of IL-1␤ and TNF-␣ on induction of ␥-GCS. These results would suggest that glucose itself may have a direct effect on transcriptional regulation of both ␥-GCS subunits, but further investigation is required.
The subunit genes are located on different chromosomes and mRNA levels and ratios of both subunits vary widely between different human tissues [12] . There are reported differences in response of ␥-GCS between in vitro and in vivo systems, tissue types, and between the subunits themselves. This is evident in the response of the subunits in HVSMC to the addition of substances that increase GSH levels. Gamma-GCS L mRNA expression is upregulated by both ␣-lipoic acid and L-cystine, whereas ␥-GCS H mRNA expression is unaffected. This is in agreement with Han et al. [23] , who observed that in human Jurkat cells, ␣-lipoic acid (100 M, 6 -14 h) increased GSH levels but did not affect ␥-GCS H mRNA expression. Recently, Kwon and Stipanuk [41] have demonstrated that ␥-GCS H is downregulated by cysteine in rat hepatocytes. They suggest that this regulation is independent of GSH levels as ␥-GCS H mRNA expression was not closely associated with the concentration of GSH. The increase in ␥-GCS L mRNA is translated into an increase in GSH levels even though there was no increase in ␥-GCS H . Tipnis et al. [42] found that overexpression of ␥-GCS L in HeLa cells increased ␥-GCS activity following GSH depletion by diethylmaleate. This increase in ␥-GCS activity was accompanied by a restoration of GSH levels. While the heavy subunit possesses the catalytic activity and is subject to negative feedback inhibition by GSH, the kinetic properties are significantly influenced by light subunit binding [11] . The magnitude of the modulatory effect of ␥-GCS L is species and cell dependent, but in all studies to date, the availability of the light subunit enhances the catalytic activity of ␥-GCS H [11, 33, 43] . Gamma-GCS L enhances the binding of ␥-GCS H to its substrates, so the elevation in GSH may be as a result of increased association of the two subunits, thereby enabling more interaction with the increased cysteine made available through the conversion from cystine. This is the first report of a reduction in mRNA of both heavy and light subunits of ␥-GCS in HVSMC treated with HG or NG/BSO for 10 d. Previous studies have reported increases in mRNA of both subunits on incubation with BSO; Tian [44] found that exposure to BSO (100 M for 12 h) caused increases in the steady state mRNA levels of both subunits in rat lung epithelial L2 cells. Similarly, Cai [45] observed activation of both subunits in rat hepatocytes treated with 0.1-5 mM BSO for 12 h. In our study, the BSO concentration was 10-fold lower and exposure was 10 d rather than 12 h. Vascular complications of diabetes are associated with long-term hyperglycemia-induced oxidative stress; therefore, a 10 d experimental period was used. It has been suggested that there is a threshold value below which the level of GSH must fall before activation of ␥-GCS occurs [33] . This may explain the reason for not observing any upregulation of the ␥-GCS subunits in BSO-treated HVSMC.
The decrease in GSH may be the primary event that predisposes the cells to oxidant-induced damage. When GSH levels are reduced in HVSMC by incubation with glucose or BSO, the amount of DNA damage is significantly increased. Treatment of the cells with ␣-lipoic acid and L-cystine, which result in the elevation of GSH levels, subsequently decrease DNA damage. In view of the association between GSH levels and amount of DNA damage, and the fact that vascular disease is responsible for most of the long-term complications of diabetes mellitus, maintenance of GSH levels in diabetic patients may prove beneficial. This may be most effectively achieved by increasing the availability of cyst(e)ine in combination with increasing the activity of ␥-GCS. Gene transfer techniques have been used to increase GSH levels through increasing activity of ␥-GCS. Mulcahy et al. [40] successfully transfected complementary DNAs for the heavy and light subunits of human ␥-GCS into COS-7 cells resulting in an elevation of intracellular glutathione.
In conclusion, we have demonstrated that hyperglycemia-induced oxidative stress occurs in HVSMC as evidenced by a decrease in GSH levels and an increase in DNA damage. The change in GSH is accompanied by a decrease in the mRNA expression of both ␥-GCS subunits. The mechanisms by which HG and BSO reduce GSH are different; BSO inactivates ␥-GCS whereas the amount of cyst(e)ine is rate-limiting in HG conditions. Addition of ␣-lipoic acid and L-cystine to HG-treated HVSMC, which increase the availability of cysteine, results in an elevation of intracellular GSH levels, upregulation of ␥-GCS L mRNA expression, and reduction in DNA damage after 24 h. The mechanisms responsible for the regulation of the ␥-GCS subunits are as yet unknown and require further investigation, but, it is evident that they are differentially regulated by high glucose in HVSMC. The study of these regulatory mechanisms is critical in the understanding of the processes involved in hyperglycemia-induced oxidative stress, which contributes to the vascular complications of diabetes. Modulation of intracellular GSH levels through pharmacological means or regulation of ␥-GCS may inhibit the hyperglycemia-induced oxidative response in diabetes.
